CPGJ602

Generic Name: CPGJ602

Brand Names: -

Drug Type: Biotech

Chemical Formula: -

CAS Number: -

Unique Ingredient Identifier: -

Background: CPGJ602 is a recombinant anti-EGFR human-mouse chimeric monoclonal antibody.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF in Metastatic Colorectal Cancer

Phase 2

Conditions: Metastatic Colorectal Cancer

Interventions: Drug: CPGJ602
Drug: cetuximab

First Posted Date: 2020-07-10

Last Posted Date: 2021-08-23

Lead Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Target Recruit Count: 75

Registration Number: NCT04466254

Locations: 🇨🇳
Chinese PLA General Hospital, Beijing, Beijing, China

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy